Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Recruiting · NCT07249840 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder | Recruiting | Phase 1 | 2026-07-28 | NCT07249840 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brigham and Women's Hospital | 378 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mass General Brigham | Boston | United States | 6 |